Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry

Florence Rabian; David Beauvais; Tony Marchand; Sabine Fürst; Anne Huynh; Eolia Brissot; Sébastien Maury; Ludovic Gabellier; Patrice Chevallier; Michael Loschi; Stéphanie Nguyen; Marie Balsat; Ingrid Lafon; Amandine Fayard; Vincent Camus; Célestine Simand; Niels Moya; Cristina Castilla-Llorente; Magalie Joris; Ana Berceanu; Anne Thiebaut-Bertrand; Véronique Lhéritier; Eve Gehlkopf; Gabrielle Roth-Guépin; Thibaut Leguay; Nicolas Boissel

doi:10.1182/bloodadvances.2024013962

Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry

Blood Adv. 2024 Nov 12;8(21):5493-5496. doi: 10.1182/bloodadvances.2024013962.

Authors

Florence Rabian^{1

2}, David Beauvais³, Tony Marchand^{4

5

6}, Sabine Fürst⁷, Anne Huynh⁸, Eolia Brissot⁹, Sébastien Maury¹⁰, Ludovic Gabellier¹¹, Patrice Chevallier¹², Michael Loschi¹³, Stéphanie Nguyen¹⁴, Marie Balsat¹⁵, Ingrid Lafon¹⁶, Amandine Fayard¹⁷, Vincent Camus¹⁸, Célestine Simand¹⁹, Niels Moya²⁰, Cristina Castilla-Llorente²¹, Magalie Joris²², Ana Berceanu²³, Anne Thiebaut-Bertrand²⁴, Véronique Lhéritier²⁵, Eve Gehlkopf²⁶, Gabrielle Roth-Guépin²⁷, Thibaut Leguay²⁸, Nicolas Boissel^{1

2}

Affiliations

¹ Hematology Adolescents and Young Adult Division, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
² Unité de Recherche Propre (URP-)3518, Institut de Recherche Saint-Louis, Université de Paris Cité, Paris, France.
³ Hematology Department, Centre Hosiptalo-Universitaire (CHU) Lille, Université Lille, Institut National de la Santé et de la Recherche Médicale (INSERM) U-1192 PRISM, Lille, France.
⁴ Hematology Department, CHU Rennes, Rennes, France.
⁵ Hematology Department, Université Rennes 1, Rennes, France.
⁶ INSERM U1236, Rennes, France.
⁷ Hematology Department, Institut Paoli-Calmettes, Marseille, France.
⁸ Hematology Department, CHU Toulouse/Institut universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France.
⁹ Department of Haematology, Sorbonne University, Saint Antoine Hospital, INSERM UMR 938, Paris, France.
¹⁰ Hematology Department, Hôpitaux universitaires Henri Mondor AP-HP and Université Paris Est Créteil, Créteil, France.
¹¹ Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France.
¹² Hematologie Department, CHU de Nantes, Nantes, France.
¹³ Hematology Department, Nice University Hospital, Cote d'Azur University, Nice, France.
¹⁴ Hematology Department, Sorbonne Université, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
¹⁵ Hématology Department, Hospices Civils de Lyon (HCL), Hôpital Lyon Sud, Pierre-Bénite, France.
¹⁶ Hematology Department, Institut de Cancérologie de Bourgogne, Polyclinique du Parc Drevon, Dijon, France.
¹⁷ Department of Clinical Hematology and Cell Therapy, CHU Estaing, Clermont-Ferrand, France.
¹⁸ Department of Hematology, Centre Henri Becquerel, Rouen, France.
¹⁹ Department of Hematology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
²⁰ Hematology Department, CHU Poitiers, Poitiers, France.
²¹ Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France.
²² Department of Clinical Hematology and Cell Therapy, CHU Amiens, Amiens, France.
²³ Department of Clinical Hematology, CHU de Besançon, Besançon, France.
²⁴ Department of Clinical Hematology, CHU Grenoble Aples, Grenoble, France.
²⁵ Hematology Department, Coordination Group for research on Adult Acute Lymphoblastic Leukemia (GRAALL), HCL, Hôpital Lyon Sud, Pierre-Bénite, France.
²⁶ Medical and Scientic Department, The Lymphoma Academic Research Organisation (LYSARC), Hôpital Lyon Sud, Pierre-Bénite, France.
²⁷ Department of Clinical Hematology, CHU NANCY, Vandoeuvre Les Nancy, France.
²⁸ Hematology Department, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France.

No abstract available